BI 3000202 Tolerability Study in Type 1 Interferonopathies Initiated
A clinical trial is underway to assess the tolerability of BI 3000202 in adults with selected type 1 interferonopathies.
Therapeutic Area
Therapeutic area intelligence for Type 1 Interferonopathies with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.